Analysis Saniona: Bridging the gap to 2020

Saniona raises capital to complete ongoing clinical trials in rare eating disorders. Ahead of the readings there is a certain event risk, however early safety reports are promising. Prospects of larger payments from partners next year supports the issue.

Read the full report (Swedish) here.